Spots Global Cancer Trial Database for endostar
Every month we try and update this database with for endostar cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma | NCT01002092 | Osteosarcoma | Chemotherapy Endostar | 12 Years - 60 Years | Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd | |
| Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer | NCT05298020 | Advanced Pancre... | Envafolimab Endostar Nab paclitaxel Gemcitabine | 18 Years - | The Affiliated Hospital of Xuzhou Medical University | |
| The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC Patients | NCT02865304 | Angiogenesis Breast Cancer | endostar | 18 Years - 70 Years | Fujian Cancer Hospital | |
| Endostar First-line Treatment of Advanced Non-small Cell Lung Squamous Carcinoma | NCT02513342 | Advanced Lung S... | Endostar Docetaxel Cisplatin | 18 Years - 75 Years | Nanjing NingQi Medicine Science and Technology Co., Ltd. | |
| Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer | NCT00708812 | Advanced Non-sm... | Endostar(Recomb... paclitaxel-carb... | 18 Years - 75 Years | Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd | |
| Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical | NCT02748772 | Colorectal Neop... | Two Anti-angiog... Pure chemothera... | 18 Years - 75 Years | The First People's Hospital of Hefei | |
| Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer | NCT03907098 | Breast Cancer | Endostar Chemotherapy | 18 Years - 70 Years | Zhejiang Cancer Hospital | |
| The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC Patients | NCT02865304 | Angiogenesis Breast Cancer | endostar | 18 Years - 70 Years | Fujian Cancer Hospital | |
| Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer | NCT03907098 | Breast Cancer | Endostar Chemotherapy | 18 Years - 70 Years | Zhejiang Cancer Hospital | |
| Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical | NCT02748772 | Colorectal Neop... | Two Anti-angiog... Pure chemothera... | 18 Years - 75 Years | The First People's Hospital of Hefei | |
| A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma | NCT02444949 | Nasopharyngeal ... | endostar intensity modul... cisplatin | 18 Years - 70 Years | China Three Gorges University, Yichang, China | |
| Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC | NCT03614065 | Non-small Cell ... | endostar Placebos radiotherapy | 18 Years - 70 Years | Wuhan Union Hospital, China | |
| Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma | NCT03086681 | Cervical Carcin... | Endostar DDP | 18 Years - 65 Years | First Affiliated Hospital of Guangxi Medical University | |
| A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients | NCT01531790 | Non-Small Cell ... | Carboplatin Pemetrexed Endostar Centrum | 18 Years - 70 Years | Jiangsu Simcere Pharmaceutical Co., Ltd. | |
| A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma | NCT01002092 | Osteosarcoma | Chemotherapy Endostar | 12 Years - 60 Years | Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd | |
| Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC) | NCT01687439 | Non-small Cell ... | Endostar Vinorelbine Cisplatin Radiotherapy | 18 Years - | Fudan University | |
| The Use of CT Perfusion to Determine the Normalization Window Period in the Treatment of Advanced Primary Lung Adenocarcinoma With Endostar | NCT01564329 | Advanced Primar... | endostar | 18 Years - 70 Years | Simcere Pharmaceutical Co., Ltd | |
| SBRT With S1 Combined With Endostar in the Treatment of Lung Cancer | NCT04274270 | Radiotherapy Si... | Endostar | 18 Years - 80 Years | Peking University Third Hospital | |
| Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma | NCT02615106 | Neuroblastoma | Endostar 21.6Gy/12Fx to ... | - | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | |
| Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma | NCT02907710 | Nasopharyngeal ... | Endostar DDP | 18 Years - 70 Years | First Affiliated Hospital of Guangxi Medical University | |
| Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC) | NCT01687439 | Non-small Cell ... | Endostar Vinorelbine Cisplatin Radiotherapy | 18 Years - | Fudan University | |
| Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma | NCT02615106 | Neuroblastoma | Endostar 21.6Gy/12Fx to ... | - | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | |
| Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance. | NCT02350361 | Lung Cancer | Recombinant hum... Placebo | 18 Years - 75 Years | Peking University Third Hospital | |
| A Trial of Endostar in Patients With Carcinoma of the Head and Neck | NCT02902432 | Nasopharyngeal ... | Endostar | 18 Years - 70 Years | China International Medical Foundation | |
| Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma | NCT01812018 | Soft Tissue Sar... | Endostar Gemcitabine Docetaxel | 18 Years - 70 Years | ChineseAMS | |
| Rh-Endostatin (Endostar®) Continuous Intravenous Infusion | NCT03706703 | Lung Cancer | Endostar Docetaxel Carboplatin Pemetrexed | 18 Years - 70 Years | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | |
| A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients | NCT01531790 | Non-Small Cell ... | Carboplatin Pemetrexed Endostar Centrum | 18 Years - 70 Years | Jiangsu Simcere Pharmaceutical Co., Ltd. | |
| Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous Melanoma | NCT05907512 | Clinical Stage ... Clinical Stage ... | Endostar Toripalimab | 18 Years - 75 Years | Fudan University | |
| Adjuvant Vinorelbine Plus Cisplatin(NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer(NSCLC) | NCT01124253 | Non-small Cell ... | recombinant hum... | 18 Years - 70 Years | Shanghai Jiao Tong University School of Medicine | |
| Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal Cancer | NCT03649945 | Esophageal Canc... | Docetaxel Nedaplatin Endostar | 18 Years - 75 Years | First Affiliated Hospital of Guangxi Medical University | |
| Endostar First-line Treatment of Advanced Non-small Cell Lung Squamous Carcinoma | NCT02513342 | Advanced Lung S... | Endostar Docetaxel Cisplatin | 18 Years - 75 Years | Nanjing NingQi Medicine Science and Technology Co., Ltd. | |
| Continuous Endostar Infusion Combined With Radiotherapy in Patients With Brain Metastases | NCT01410370 | Brain Metastase... | 6MV-X ray Endostar | 18 Years - 75 Years | Jiangsu Simcere Pharmaceutical Co., Ltd. | |
| Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma | NCT03932266 | Nasopharyngeal ... | Endostar Cisplatin Docetaxel Intensity Modul... | 18 Years - 70 Years | Jiangsu Cancer Institute & Hospital | |
| A Study of Endostar Combined With Chemotherapy Followed by Endostar Maintenance Therapy to Treat Advanced Non-small Cell Lung Cancer (NSCLC) | NCT01028729 | Non-small Cell ... | Endostar Gemcitabine-Cis... | 18 Years - 75 Years | Simcere Pharmaceutical Co., Ltd | |
| SBRT With S1 Combined With Endostar in the Treatment of Lung Cancer | NCT04274270 | Radiotherapy Si... | Endostar | 18 Years - 80 Years | Peking University Third Hospital | |
| Safety Study of Combined Chemotherapy and Endostar to Untreated Patients With Advanced Melanoma | NCT00813449 | Advanced Melano... Untreated Patie... | dacarbazine plu... dacarbazine plu... | 18 Years - 75 Years | Simcere Pharmaceutical Co., Ltd | |
| Evaluate the Treatment With Sintilimab Injection Plus Endostar in Hepatocellular Carcinoma | NCT03881501 | Hepatocellular ... | 18 Years - 75 Years | Huazhong University of Science and Technology | ||
| Rh-endostatin in Combination With Dacarbazine and Cisplatin as the First Line Therapy for Metastatic Melanoma | NCT03095079 | Melanoma | recombinant hum... | 18 Years - 70 Years | Peking University Cancer Hospital & Institute | |
| Endostar for Locally Recurrent Nasopharyngeal Carcinoma | NCT02636231 | Nasopharyngeal ... | Endostatins IMRT | 18 Years - 70 Years | Sun Yat-sen University | |
| A Study of Endostar Combined With Chemotherapy Followed by Endostar Maintenance Therapy to Treat Advanced Non-small Cell Lung Cancer (NSCLC) | NCT01028729 | Non-small Cell ... | Endostar Gemcitabine-Cis... | 18 Years - 75 Years | Simcere Pharmaceutical Co., Ltd | |
| Endostar Continued Pumping Into Vein Combining With Gemcitabine-Carboplatin to Treat Non-Small Cell Lung Cancer (NSCLC) | NCT01549093 | Non-small Cell ... | Gemcitabine,Car... Gemcitabine(G) ... Gemcitabine(G) ... | 18 Years - 70 Years | Hunan Province Tumor Hospital | |
| Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma | NCT03086681 | Cervical Carcin... | Endostar DDP | 18 Years - 65 Years | First Affiliated Hospital of Guangxi Medical University | |
| The Use of CT Perfusion to Determine the Normalization Window Period in the Treatment of Advanced Primary Lung Adenocarcinoma With Endostar | NCT01564329 | Advanced Primar... | endostar | 18 Years - 70 Years | Simcere Pharmaceutical Co., Ltd | |
| Endostar Combined With Corticosteroid for Treatment of Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma | NCT05177237 | Nasopharyngeal ... | Endostar | 18 Years - | Jiangxi Provincial Cancer Hospital | |
| Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas | NCT02665702 | Esophageal Squa... | NVB DDP Endostar | 18 Years - 75 Years | Fudan University | |
| Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical | NCT02748772 | Colorectal Neop... | Two Anti-angiog... Pure chemothera... | 18 Years - 75 Years | The First People's Hospital of Hefei | |
| Evaluate the Treatment With Sintilimab Injection Plus Endostar in Hepatocellular Carcinoma | NCT03881501 | Hepatocellular ... | 18 Years - 75 Years | Huazhong University of Science and Technology | ||
| Endostar First-line Treatment of Advanced NSCLC | NCT03123445 | Non Small Cell ... | Endostar Gemcitabine Cisplatin | 18 Years - 75 Years | China Medical University, China | |
| Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma | NCT03932266 | Nasopharyngeal ... | Endostar Cisplatin Docetaxel Intensity Modul... | 18 Years - 70 Years | Jiangsu Cancer Institute & Hospital | |
| The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC Patients | NCT02865304 | Angiogenesis Breast Cancer | endostar | 18 Years - 70 Years | Fujian Cancer Hospital | |
| Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical | NCT02748772 | Colorectal Neop... | Two Anti-angiog... Pure chemothera... | 18 Years - 75 Years | The First People's Hospital of Hefei | |
| CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer | NCT04121975 | Cervical Cancer | Radiotherapy Endostar Cisplatin | 18 Years - 65 Years | Zhejiang Cancer Hospital | |
| Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC) | NCT00912392 | Small Cell Lung... | Endostar Etoposide-Carbo... | 18 Years - 75 Years | Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd | |
| Endostar Durative Transfusion Combining With Gemcitabine-Cisplatin to Treat Non-Small Cell Lung Cancer (NSCLC) | NCT01669707 | Non-small Cell ... | Endostar -Conti... Endostar -injec... | 18 Years - 75 Years | Beijing Chest Hospital | |
| CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer | NCT04121975 | Cervical Cancer | Radiotherapy Endostar Cisplatin | 18 Years - 65 Years | Zhejiang Cancer Hospital | |
| Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas | NCT03797625 | Esophageal Squa... | Irinotecan DDP Endostar | 18 Years - 75 Years | Fudan University | |
| A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma | NCT02444949 | Nasopharyngeal ... | endostar intensity modul... cisplatin | 18 Years - 70 Years | China Three Gorges University, Yichang, China | |
| The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC Patients | NCT02865304 | Angiogenesis Breast Cancer | endostar | 18 Years - 70 Years | Fujian Cancer Hospital | |
| Safety Study of Combined Chemotherapy and Endostar to Untreated Patients With Advanced Melanoma | NCT00813449 | Advanced Melano... Untreated Patie... | dacarbazine plu... dacarbazine plu... | 18 Years - 75 Years | Simcere Pharmaceutical Co., Ltd | |
| PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy | NCT04942301 | Advanced or Met... | Endostar use the vein pu... combination the... | 18 Years - | Jiangsu Simcere Pharmaceutical Co., Ltd. | |
| Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC) | NCT00912392 | Small Cell Lung... | Endostar Etoposide-Carbo... | 18 Years - 75 Years | Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd | |
| Evaluate the Treatment With Sintilimab Injection Plus Endostar in Hepatocellular Carcinoma | NCT03881501 | Hepatocellular ... | 18 Years - 75 Years | Huazhong University of Science and Technology | ||
| Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors | NCT06301828 | Gastrointestina... | Envafolimab Inj... Endostar | 18 Years - 75 Years | Nanjing First Hospital, Nanjing Medical University | |
| Postoperative Concurrent Chemoradiotherapy Combined With Endostar for High-risk Early Stage Cervical Cancer | NCT03622827 | Uterine Cervica... | Chemoradiothera... | 18 Years - 70 Years | Nanjing Medical University | |
| Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLC | NCT05203276 | Lung Neoplasms | Envafolimab Endostar | 18 Years - 80 Years | The First People's Hospital of Lianyungang | |
| Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma | NCT03086681 | Cervical Carcin... | Endostar DDP | 18 Years - 65 Years | First Affiliated Hospital of Guangxi Medical University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
